Skip to main content
Log in

Mechanism of estrogen-induced apoptosis in breast cancer cells: Role of the NF-κB signaling pathway

  • Published:
Biochemistry (Moscow) Aims and scope Submit manuscript

Abstract

The ability of sex steroid hormones to up-regulate the apoptotic signaling proteins is well documented; however, the apoptotic potential of sex hormones is not remarkable and fully compensated by their growth stimulatory action to target cells. In the present study using the long-term cultivation of estrogen-dependent MCF-7 breast cancer cells in steroid-free medium, we have established a cell subline, designed as MCF-7/LS, which was characterized by the resistance to growth stimulatory estradiol action and hypersensitivity to estrogen-induced apoptosis. We have demonstrated that estrogen treatment of the cells does not influence on the level of TNF-R1 or Fas, but dramatically decreases the transcriptional activity of NF-κB. Importantly, the MCF-7/LS cells, which are insensitive to growth stimulatory estrogen action, retain the ability to decrease in the NF-κB activity in response to estrogen stimulus. Furthermore, the significant increase in the basal (in the absence of ligand) estrogen receptor (ER)-dependent transcriptional activity in the MCF-7/LS cells was revealed and reciprocal transcriptional antagonism between ER and NF-κB was demonstrated. Finally, we proved the possible involvement of phosphatidylinositol-3 kinase (PI3K) in the ligand-independent ER activation. In general, the results presented suggest that long-term growth of MCF-7 breast cancer cells in steroid-free medium is accompanied with the increase in the basal ER-dependent transcriptional activity as well as the maintenance of the negative regulatory loop ER-NF-κB. The latter may be considered as one of the factors resulting in a disbalance between pro-and anti-apoptotic pathways and enhancement in estrogen apoptotic action in the cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

ER:

estrogen receptor

ERE:

estrogen responsive element

MTT:

3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide

PI:

propidium iodide

PI3K:

phosphatidylinositol-3 kinase

PTEN:

phosphatase dephosphorylating 3-OH-phosphoinositides

TNF-α:

tumor necrosis factor α

TNF-R1:

type I tumor necrosis factor receptor

References

  1. Krasil’nikov, M. A. (2004) Vopr. Onkol., 50, 399–405.

    PubMed  CAS  Google Scholar 

  2. Bershtein, L. M., and Santen, R. (2002) Vopr. Onkol., 48, 17–23.

    Google Scholar 

  3. Normanno, N., di Maio, M., de Maio, E., de Luca, A., de Matteis, A., Giordano, A., and Perrone, F. (2005) Endocr. Relat. Cancer, 12, 721–747.

    Article  PubMed  CAS  Google Scholar 

  4. Clarke, R., Liu, M. C., Bouker, K. B., Gu, Z., Lee, R. Y., Zhu, Y., Skaar, T. C., Gomez, B., O’Brien, K., Wang, Y., and Hilakivi-Clarke, L. A. (2003) Oncogene, 22, 7316–7339.

    Article  PubMed  CAS  Google Scholar 

  5. Jordan, V. C. (2003) Ann. Oncol., 14, 969–970.

    Article  PubMed  CAS  Google Scholar 

  6. Beekman, J. M., Allan, G. F., Tsai, S. Y., Tsai, M. J., and O’Malley, B. W. (1993) Mol. Endocrinol., 7, 1266–1274.

    Article  PubMed  CAS  Google Scholar 

  7. Leclercq, G., Lacroix, M., Laios, I., and Laurent, G. (2006) Curr. Cancer Drug Targets, 6, 39–64.

    Article  PubMed  CAS  Google Scholar 

  8. Marino, M., Acconcia, F., and Ascenzi, P. (2005) Curr. Drug Targets Immune Endocr. Metab. Disord., 5, 305–314.

    Article  CAS  Google Scholar 

  9. Campbell, R. A., Bhat-Nakshatri, P., Patel, N. M., Constantinidou, D., Ali, S., and Nakshatri, H. (2001) J. Biol. Chem., 276, 9817–9824.

    Article  PubMed  CAS  Google Scholar 

  10. Rollerova, E., and Urbancikova, M. (2000) Endocr. Regul., 34, 203–218.

    PubMed  CAS  Google Scholar 

  11. Ring, A., and Dowsett, M. (2004) Endocr. Relat. Cancer, 11, 643–658.

    Article  PubMed  CAS  Google Scholar 

  12. Stoica, G. E., Franke, T. F., Wellstein, A., Czubayko, F., List, H. J., Reiter, R., Morgan, E., Martin, M. B., and Stoica, A. (2003) Mol. Endocrinol., 17, 818–830.

    Article  PubMed  CAS  Google Scholar 

  13. Song, R. X., Mor, G., Naftolin, F., McPherson, R. A., Song, J., Zhang, Z., Yue, W., Wang, J., and Santen, R. J. (2001) J. Natl. Cancer Inst., 93, 1714–1723.

    Article  PubMed  CAS  Google Scholar 

  14. Song, R. X., and Santen, R. J. (2003) Apoptosis, 8, 55–60.

    Article  PubMed  CAS  Google Scholar 

  15. Song, R. X., Zhang, Z., Mor, G., and Santen, R. J. (2005) Apoptosis, 10, 667–678.

    Article  PubMed  CAS  Google Scholar 

  16. Liu, H., Lee, E. S., Gajdos, C., Pearce, S. T., Chen, B., Osipo, C., Loweth, J., McKian, K., De Los Reyes, A., Wing, L., and Jordan, V. C. (2003) J. Natl. Cancer Inst., 95, 1586–1597.

    PubMed  CAS  Google Scholar 

  17. Osipo, C., Gajdos, C., Liu, H., Chen, B., and Jordan, V. C. (2003) J. Natl. Cancer Inst., 95, 1597–1608.

    PubMed  CAS  Google Scholar 

  18. Shcherbakov, A. M., Lobanova, Yu. S., Shatskaya, V. A., Onopchenko, O. V., Gasparian, A. V., Gershtein, E. S., and Krasil’nikov, M. A. (2006) Byul. Eksp. Biol. Med., 141, 334–337.

    Article  CAS  Google Scholar 

  19. Lewis, J. S., Osipo, C., Meeke, K., and Jordan, V. C. (2005) J. Steroid Biochem. Mol. Biol., 94, 131–141.

    Article  PubMed  CAS  Google Scholar 

  20. Osipo, C., Gajdos, C., Cheng, D., and Jordan, V. C. (2005) J. Steroid Biochem. Mol. Biol., 93, 249–256.

    Article  PubMed  CAS  Google Scholar 

  21. Lonning, P. E., Taylor, P. D., Anker, G., Iddon, J., Wie, L., Jorgensen, L. M., Mella, O., and Howell, A. (2001) Breast Cancer Res. Treat., 67, 111–116.

    Article  PubMed  CAS  Google Scholar 

  22. Peethambaram, P. P., Ingle, J. N., Suman, V. J., Hartmann, L. C., and Loprinzi, C. L. (1999) Breast Cancer Res. Treat., 54, 117–122.

    Article  PubMed  CAS  Google Scholar 

  23. Jordan, V. C., Osipo, C., Schafer, J. M., Fox, J. E., Cheng, D., and Liu, H. (2003) Breast, 12, 432–441.

    Article  PubMed  CAS  Google Scholar 

  24. Osipo, C., Liu, H., Meeke, K., and Jordan, V. C. (2004) Exp. Biol. Med. (Maywood), 229, 722–731.

    CAS  Google Scholar 

  25. Okumura, N., Saji, S., Eguchi, H., Hayashi, S., Saji, S., and Nakashima, S. (2002) Jap. J. Cancer Res., 93, 867–873.

    CAS  Google Scholar 

  26. Saji, S., Nakashima, S., Hayashi, S., Toi, M., Saji, S., and Nozawa, Y. (1999) Jap. J. Cancer Res., 90, 210–218.

    CAS  Google Scholar 

  27. Mor, G., Kohen, F., Garcia-Velasco, J., Nilsen, J., Brown, W., Song, J., and Naftolin, F. (2000) J. Steroid Biochem. Mol. Biol., 73, 185–194.

    Article  PubMed  CAS  Google Scholar 

  28. Lewis, J. S., Meeke, K., Osipo, C., Ross, E. A., Kidawi, N., Li, T., Bell, E., Chandel, N. S., and Jordan, V. C. (2005) J. Natl. Cancer Inst., 97, 1746–1759.

    Article  PubMed  CAS  Google Scholar 

  29. Provost, P. R., Blomquist, C. H., Godin, C., Huang, X. F., Flamand, N., Luu-The, V., Nadeau, D., and Tremblay, Y. (2000) Endocrinology, 141, 2786–2794.

    Article  PubMed  CAS  Google Scholar 

  30. Krasil’nikov, M. A., Shatskaya, V. A., Stavrovskaya, A. A., Erohina, M., Gershtein, E. S., and Adler, V. V. (1999) Biochim. Biophys. Acta, 1450, 434–443.

    Article  PubMed  CAS  Google Scholar 

  31. Olea-Serrano, N., Devleeschouwer, N., Leclercq, G., and Heuson, J. C. (1985) Eur. J. Cancer Clin. Oncol., 21, 965–973.

    Article  PubMed  CAS  Google Scholar 

  32. Reid, G., Hubner, M. R., Metivier, R., Brand, H., Denger, S., Manu, D., Beaudouin, J., Ellenberg, J., and Gannon, F. (2003) Mol. Cell, 11, 695–707.

    Article  PubMed  CAS  Google Scholar 

  33. Gasparian, A. V., Yao, Y. J., Kowalczyk, D., Lyakh, L. A., Karseladze, A., Slaga, T. J., and Budunova, I. V. (2002) J. Cell Sci., 115, 141–151.

    PubMed  CAS  Google Scholar 

  34. Tolkacheva, T., and Chan, A. M. (2000) Oncogene, 19, 680–689.

    Article  PubMed  CAS  Google Scholar 

  35. Hotz, M. A., Gong, J., Traganos, F., and Darzynkiewicz, Z. (1994) Cytometry, 15, 237–244.

    Article  PubMed  CAS  Google Scholar 

  36. Danforth, D. N., and Zhu, Y. (2005) Breast Cancer Res. Treat., 94, 81–91.

    Article  PubMed  CAS  Google Scholar 

  37. Galea, E., Santizo, R., Feinstein, D. L., Adamsom, P., Greenwood, J., Koenig, H. M., and Pelligrino, D. A. (2002) Neuroreport, 13, 1469–1472.

    Article  PubMed  CAS  Google Scholar 

  38. Biswas, D. K., Singh, S., Shi, Q., Pardee, A. B., and Iglehart, J. D. (2005) Sci. STKE, 288, 27–32.

    Google Scholar 

  39. Kalaitzidis, D., and Gilmore, T. D. (2005) Trends Endocrinol. Metab., 16, 46–52.

    Article  PubMed  CAS  Google Scholar 

  40. Pratt, M. A., Bishop, T. E., White, D., Yasvinski, G., Menard, M., Niu, M. Y., and Clarke, R. (2003) Mol. Cell. Biol., 23, 6887–6900.

    Article  PubMed  CAS  Google Scholar 

  41. Stoica, G. E., Franke, T. F., Moroni, M., Mueller, S., Morgan, E., Iann, M. C., Winder, A. D., Reiter, R., Wellstein, A., Martin, M. B., and Stoica, A. (2003) Oncogene, 22, 7998–8011.

    Article  PubMed  CAS  Google Scholar 

  42. Vilgelm, A., Lian, Z., Wang, H., Beauparlant, S. L., Klein-Szanto, A., Ellenson, L. H., and di Cristofano, A. (2006) Cancer Res., 66, 3375–3380.

    Article  PubMed  CAS  Google Scholar 

  43. Aquila, S., Sisci, D., Gentile, M., Middea, E., Catalano, S., Carpino, A., Rago, V., and Ando, S. (2004) J. Clin. Endocrinol. Metab., 89, 1443–1451.

    Article  PubMed  CAS  Google Scholar 

  44. Evans, M. J., Eckert, A., Lai, K., Adelman, S. J., and Harnish, D. C. (2001) Circ. Res., 89, 823–830.

    PubMed  CAS  Google Scholar 

  45. McKay, L. I., and Cidlowski, J. A. (1999) Endocr. Rev., 20, 435–459.

    Article  PubMed  CAS  Google Scholar 

  46. Wajant, H., Pfizenmaier, K., and Scheurich, P. (2003) Cell Death Differ., 10, 45–65.

    Article  PubMed  CAS  Google Scholar 

  47. Ariazi, E. A., and Jordan, V. C. (2006) Curr. Top. Med. Chem., 6, 203–215.

    PubMed  CAS  Google Scholar 

  48. Zhou, W., Liu, Z., Wu, J., Liu, J. H., Hyder, S. M., Antoniou, E., and Lubahn, D. B. (2006) J. Clin. Endocrinol. Metab., 91, 569–579.

    Article  PubMed  CAS  Google Scholar 

  49. Kurokawa, H., Lenferink, A. E., Simpson, J. F., Pisacane, P. I., Sliwkowski, M. X., Forbes, J. T., and Arteaga, C. L. (2000) Cancer Res., 60, 5887–5894.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. A. Krasil’nikov.

Additional information

Original Russian Text © Yu. S. Lobanova, A. M. Scherbakov, V. A. Shatskaya, M. A. Krasil’nikov, 2007, published in Biokhimiya, 2007, Vol. 72, No. 3, pp. 392–401.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lobanova, Y.S., Scherbakov, A.M., Shatskaya, V.A. et al. Mechanism of estrogen-induced apoptosis in breast cancer cells: Role of the NF-κB signaling pathway. Biochemistry Moscow 72, 320–327 (2007). https://doi.org/10.1134/S0006297907030108

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S0006297907030108

Key words

Navigation